New Key Statistics Module, Z-Score and F-Score
NAS:AXSM Key Ratios
Market Cap $ M | 3,489.52 |
Enterprise Value $ M | 3,347.51 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 24.21 |
Price/Sales | 13.63 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 251.00 |
EPS (TTM) $ | -6.38 |
Beneish M-Score | -2.04 |
10-y EBITDA Growth Rate % | -34.20 |
5-y EBITDA Growth Rate % | -33.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -11.44 |
EV-to-EBITDA | -11.72 |
PEG | -- |
Shares Outstanding M | 47.50 |
Net Margin (%) | -118.07 |
Operating Margin % | -97.62 |
Pre-tax Margin (%) | -118.71 |
Quick Ratio | 3.09 |
Current Ratio | 3.20 |
ROA % (ttm) | -54.17 |
ROE % (ttm) | -148.91 |
ROIC % (ttm) | -226.08 |
Dividend Yield % | -- |
Altman Z-Score | 2.28 |
AXSM Number of Guru Trades
AXSM Volume of Guru Trades
Gurus Latest Trades with NAS:AXSM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AXSM is held by these investors
Total 1
Axsome Therapeutics Inc Insider Transactions
No Available Data
News about NAS:AXSM
Total 0- 1